Symptom-centric view

Loss of personal independence in daily activities

Substances reporting Loss of personal independence in daily activities disproportionately — ranked by ROR.

Pain Drug ineffective Off label use Fatigue Dyspnoea Acute kidney injury

showing 61 of 61

Substance ↓	ROR [95% CI]	Reports	Category	Label
zuranolone —	9.9 [6.9–14.3]	29	algemeen	new
zafirlukast —	11.6 [7.6–17.7]	22	algemeen	new
umeclidinium —	5.4 [5.0–5.8]	747	algemeen	new
tiotropium bromide inhalation spray —	22.7 [20.8–24.8]	519	algemeen	new
tiotropium bromide —	12.0 [11.6–12.4]	3,686	algemeen	new
theophylline anhydrous —	12.1 [10.8–13.5]	322	algemeen	new
theophylline —	12.1 [10.8–13.5]	322	algemeen	new
terbutaline sulfate —	36.5 [30.6–43.5]	136	algemeen	new
tamsulosin hydrochloride —	8.2 [7.4–9.1]	369	algemeen	new
sulfadiazine —	11.7 [9.6–14.2]	99	algemeen	new
salmeterol xinafoate —	11.2 [10.6–11.7]	1,600	algemeen	new
rilpivirine hydrochloride —	5.6 [4.8–6.6]	156	algemeen	new
reslizumab —	7.4 [4.1–13.5]	11	algemeen	new
raltegravir —	9.8 [8.8–10.9]	352	algemeen	new
prednisolone sodium phosphate —	10.8 [8.3–14.1]	57	algemeen	new
pioglitazone hydrochloride —	13.3 [9.6–18.5]	37	algemeen	new
penicillin v potassium —	19.2 [15.8–23.4]	102	algemeen	new
penicillin g —	7.5 [6.0–9.3]	79	algemeen	new
nelfinavir mesylate —	9.3 [6.9–12.6]	43	algemeen	new
montelukast sodium —	11.7 [11.3–12.2]	2,894	algemeen	new
montelukast —	10.0 [9.7–10.3]	3,525	algemeen	new
mepolizumab —	46.4 [44.9–48.0]	4,206	algemeen	new
lopinavir and ritonavir —	11.8 [10.6–13.1]	347	algemeen	new
lisdexamfetamine dimesylate capsules —	17.5 [15.0–20.3]	173	algemeen	new
liothyronine sodium —	13.6 [12.0–15.4]	253	algemeen	new
ipratropium bromide —	11.1 [10.4–11.8]	931	algemeen	new
glucagon —	17.8 [15.1–20.9]	156	algemeen	new
formoterol fumarate dihydrate —	10.8 [10.4–11.2]	2,580	algemeen	new
formoterol fumarate —	10.0 [9.6–10.4]	2,620	algemeen	new
fluticasone propionate and salmeterol xinafoate —	12.4 [11.8–13.1]	1,565	algemeen	new
fluticasone furoate, umeclidinium bromide and vilanterol trifenatate —	5.9 [5.4–6.5]	513	algemeen	new
fluticasone furoate and vilanterol trifenatate —	18.5 [17.5–19.5]	1,371	algemeen	new
fluticasone furoate —	11.4 [10.9–11.9]	2,030	algemeen	new
febuxostat tablets 80 mg —	8.9 [7.7–10.2]	192	algemeen	new
febuxostat tablets 40 mg —	8.9 [7.7–10.2]	192	algemeen	new
febuxostat —	7.1 [6.3–8.0]	256	algemeen	new
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate —	4.5 [3.5–5.7]	67	algemeen	new
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide —	5.5 [4.0–7.4]	43	algemeen	new
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate —	5.9 [4.9–7.1]	118	algemeen	new
elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide —	6.2 [5.2–7.3]	136	algemeen	new
efavirenz —	8.9 [7.8–10.2]	218	algemeen	new
dolutegravir sodium and rilpivirine hydrochloride —	14.6 [11.2–19.1]	55	algemeen	new
deutetrabenazine —	9.5 [8.1–11.3]	143	algemeen	new
darunavir ethanolate and cobicistat —	21.3 [17.0–26.7]	80	algemeen	new
cobicistat —	5.9 [5.2–6.6]	269	algemeen	new
ciclesonide —	70.5 [67.0–74.2]	1,772	algemeen	new
cefuroxime sodium —	30.9 [24.5–39.0]	76	algemeen	new
cefuroxime axetil —	15.9 [13.2–19.2]	117	algemeen	new
calcium sennosides —	188.5 [137.1–259.2]	54	algemeen	new
budesonide and formoterol fumarate dihydrate —	11.6 [11.1–12.1]	2,323	algemeen	new
budesonide —	10.7 [10.3–11.1]	3,521	algemeen	new
bimekizumab —	6.5 [5.7–7.4]	233	algemeen	new
aztreonam —	6.0 [4.9–7.3]	94	algemeen	new
atazanavir sulfate —	36.8 [32.1–42.2]	226	algemeen	new
atazanavir —	11.9 [10.8–13.2]	376	algemeen	new
anakinra —	16.0 [14.7–17.4]	557	algemeen	new
albuterol sulfate —	10.1 [9.8–10.3]	5,724	algemeen	new
albuterol —	10.0 [9.7–10.3]	5,734	algemeen	new
aclidinium bromide —	22.3 [19.8–25.0]	303	algemeen	new
abaloparatide —	15.9 [14.9–17.1]	855	algemeen	new
abacavir sulfate, dolutegravir sodium, lamivudine —	7.7 [6.3–9.3]	107	algemeen	new

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).